DaVita Inc., a leading provider of kidney care services for those diagnosed with chronic kidney failure and disease (CKD), recently announced that Debbie Benner, MA, RD, CSR, National Director of Nutrition Services for DaVita® and Mary Burgess, RD, Grant Program Manager for DaVita Clinical Research® have been invited to present five abstracts at the XIV International Congress on Nutrition and Metabolism in Renal Disease in Marseilles, France on June 11-15, 2008.

(Logo: http://www.newscom.com/cgi-bin/prnh/20020729/DAVITALOGO)

Benner and Burgess will join attendees from more than 40 countries to participate in this year's congress, hosted by the International Society of Nutrition and Metabolism, whose mission is to advance the knowledge of nutrition and metabolism in renal disease and renal failure and to foster communication of the advancement of this knowledge by means of scientific meetings and cooperation with scientific societies covering nephrology, nutrition, biochemistry and physiology.

The DaVita abstracts, co-authored by Benner, Burgess, David Van Wyck, MD, Kamyar Kalantar, MD and Chhaya Patel, RD, CSR, focus on the topic of albumin and mineral bone disorder management. Benner will present the oral abstracts during the educational sessions and Burgess will present the poster abstracts during scientific symposia. The Journal of Renal Nutrition will also publish the abstracts in its May issue.

"Those who care for dialysis patients struggle particularly with nutrition and mineral bone disease," said Dr. Van Wyck. "The results that will be presented in Marseilles are important not just because DaVita's clinical outcomes are impressive. They will show how to measure, organize and achieve great outcomes throughout the entire kidney care community."

DaVita and DaVita Clinical Research are trademarks of DaVita Inc. All other trademarks are the property of their respective owners.

About DaVita Inc.

DaVita Inc., a FORTUNE 500® company, is a leading provider of kidney care in the United States, providing dialysis services and education for patients with chronic kidney failure and end stage renal disease. DaVita manages more than 1,300 outpatient facilities and acute units in more than 700 hospitals located in 43 states and the District of Columbia, serving approximately 107,000 patients. For more information about DaVita and its kidney education programs, please visit http://www.davita.com/.

First Call Analyst:
FCMN Contact:

SOURCE: DaVita Inc.